# Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the Prostate

> **NCT04403568** · EARLY_PHASE1 · WITHDRAWN · sponsor: **The University of Texas Health Science Center at San Antonio**

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Ursolic Acid
- **DRUG:** Curcumin

## Key facts

- **NCT ID:** NCT04403568
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-10
- **Primary completion:** 2022-12
- **Final completion:** 2023-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No subjects were enrolled in this study, the PI will seek funding and revise the protocol for resubmisson at a later date
- **Last updated:** 2021-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04403568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04403568, "Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the Prostate". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04403568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
